QTRX — Quanterix Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapValue Trap

Annual income statement for Quanterix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K/A	10-K/A	10-K/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	111	106	122	137	139
Cost of Revenue
Gross Profit	64.8	45.4	74.2	83.1	65
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	167	210	168	190	264
Operating Profit	-56.5	-104	-46	-52.6	-126
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-55.6	-99.4	-27.6	-38.1	-112
Provision for Income Taxes
Net Income After Taxes	-55.5	-99.6	-28.4	-38.5	-107
Net Income Before Extraordinary Items
Net Income	-55.5	-99.6	-28.4	-38.5	-107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-55.5	-99.6	-28.4	-38.5	-107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.54	-2.17	-0.731	-1	-2.02